ChargariC Profile Banner
Chargari Cyrus Profile
Chargari Cyrus

@ChargariC

Followers
94
Following
2
Statuses
8

Professor of radiation oncology @gustaveroussy Chair of brachytherapy, Gustave Roussy Cancer Campus MD, PhD, #brachytherapy @sfro_fr #ESTRO

Joined January 2020
Don't wanna be here? Send us removal request.
@ChargariC
Chargari Cyrus
2 years
RT @AMaulard: @ChargariC #ESGO2022 #gustaveroussy Excellent presentation
Tweet media one
0
2
0
@ChargariC
Chargari Cyrus
3 years
@supriyasastri @ACTREC_TMC @TataMemorial @RadOncTMC Great team and outstanding contribution to brachytherapy developments
1
0
0
@ChargariC
Chargari Cyrus
3 years
RT @AFCOR_: 📢📅L' #AFCOR_ organise une soirée virtuelle "Les Cas Pratiques de l'AFCOR sur l'Endomètre" le jeudi 17 mars 2022 de 19h00 à 20h0…
0
7
0
@ChargariC
Chargari Cyrus
3 years
RT @JContBrachyther: Residual distal parametrial involvement after radiochemotherapy is a true challenge for brachytherapists since the wid…
0
3
0
@ChargariC
Chargari Cyrus
3 years
RT @Mat_Guc: International Delphi consensus for pelvic Stereotactic Ablative Radiotherapy reirradiation -> important field of research due…
0
42
0
@ChargariC
Chargari Cyrus
3 years
Major study that should change standard in metastatic and recurrent cervical cancer patients. Next step is to reduce systemic recurrence rate in locally advanced setting. We hope ongoing trials combining CRT with immunotherapy will also translate into benefits for patients!
@DrChoueiri
Toni Choueiri, MD
3 years
#ESMO21 : Promising activity of Pembro + Chemo in metastatic cervical cancer with a survival benefit consistent across major key subgroups and acceptable QoL!! @myESMO
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
1
@ChargariC
Chargari Cyrus
3 years
RT @jdfumet: KEYNOTE 826 : Bénéfice en PFS et en OS pour le pembrolizumab en association avec la chimiothérapie + bevacizumab #cervicalcanc…
0
7
0
@ChargariC
Chargari Cyrus
3 years
RT @AdamChiche: #High-#frequency #ultrasound #HFUS supports diagnosis and management of #skincancer. Provides essential information on tumo…
0
2
0